Arvind Remedies has announced its financial results for the fourth quarter and full year ended March 31, 2014. The net sales for Q4FY13-14 increased by 57 per cent to Rs 274 crore as compared to Rs 174 crore of Q4FY12-13. Earnings before interest, taxes, depreciation, and amortization (EBIDTA) for Q4FY13-14 registered a sharp jump of 39 per cent and improved to Rs 53 crore as compared to Rs 38 crore in Q4FY12-13. PAT for Q4FY13-14 is at Rs 11 crore as against Rs.12 crore in Q4FY12-13.
Net sales for FY13-14 has jumped to Rs 911 crore in comparison to Rs.664 crore of FY12-13, up by 37 per cent. EBIDTA for FY13-14 rose to Rs 177 crore up by 32 per cent as compared to Rs 134 crore in FY12-13. PAT for FY13-14 has increased to Rs 59 crore as against Rs 41 crore in FY12-13 up by 44 per cent Y-o-Y.
Dr Arvind Shah, Managing Director and Chief Executive Officer, Arvind Remedies said, “We are happy with our performance in Q4FY14 and FY14. During the year our sales volume grew by 37 per cent and our profit has grown by 47 per cent Y-o-Y. We expect all our segments to perform well on the back of strong demand for all our products. Our focus is on the retail brand business. This year we have marked our presence in two more states, so making our presence in total 10 states and we are planning to have PAN India presence in the upcoming two years.
EP News Bureau- Mumbai